BC Cancer Agency-Vancouver

Vancouver, British Columbia V5Z4E6

1 studies enrolling now · 9 studies all time

What they study most

Advanced Pancreatic Cancer, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Liposarcoma, Dedifferentiated, Malignant Melanoma, Metastatic Pancreatic Cancer, Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Prostate Neoplasms, Solid Tumors, Solid Tumours

Studies at this site

• Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations — Recruiting now
• Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma — Completed
• Pancreatic Adenocarcinoma Signature Stratification for Treatment — Completed
• A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors. — Stopped early
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas — Completed
• A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma — Completed
• Real World Data on Gi(l)Otrif® Dose Adjustment — Completed
• LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment — Completed
• A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer — Completed